Skip to main content
. 2014 Jan 23;23(12):3157–3165. doi: 10.1093/hmg/ddu026

Figure 3.

Figure 3

PRDX3 and Ebselen ameliorate mutant-induced motor dysfunction. (A) Age-dependent climbing scores as percent of mean ± SEM (n = 3, cohort of 50) normalized to control. **Significant increase from G2019S values at P < 0.01 by one-way ANOVA with Bonferroni corrections. (B) Climbing scores as in (A). (C) DA neuronal counts by cluster (n = 3, cohort of 20). *,**Significant difference at P < 0.05 and P < 0.01 by one-way ANOVA with Bonferroni corrections.